Although there are experimental and clinical evidences regarding oxidant-antioxidant disturbance in hypertension, clinical data supporting the same in prehypertensive subjects is lacking. Prehypertension (PHT) has been recently described as an independent category of blood pressure (BP). According to Joint National Committee -7 (JNC-7) report, the term PHT includes the individuals whose systolic BP falls in the range 120-139 mm Hg and diastolic BP in 80-89 mm Hg. 1 Das et al. 2 have reported that PHT is present in about 58.7% of adults in urban India. Even though the cause of PHT remains unclear, previous studies have documented it as a proinflammatory condition and suggested that it is associated with an increased risk of both heart disease and stroke.
3,4 JNC report on hypertension identifies PHT as one of the risk factors for developing hypertension, 1 and oxidative stress may be the common denominator in the development of hypertension in potentially high-risk groups.
As in other cardiovascular diseases, a growing number of reports have assigned a critical role for oxidative stress in the pathogenesis of hypertension. 5 It has also been reported that at young age, the prevalence of hypertension is higher in men than in women. 6 One of the major causes of the rapid increase in hypertensive population in urban areas can be given to globalization. Globalization has accelerated the dietary and lifestyle shifts, particularly in the developing world, where the nutrition transition has taken place at a faster pace, putting these populations at a greater risk of hypertension. As oxidative stress can be modulated by nutritional, genetic and environmental factors, it was deemed pertinent to study the oxidative stress parameters in non-obese prehypertensive subjects. To our knowledge, this is the first study to compare the oxidative stress parameters in prehypertensive subjects against normotensive controls.
The present study comprises 31 prehypertensive and 26 normotensive subjects in the age group 25-50 years and body mass index (BMI) o30 kg/m 2 . BP was recorded as per recommendation of British Hypertension Society. BP was measured in three different sittings across 3 weeks. In each visit, three readings were taken, and the average of the three values was taken for the study and the subjects were classified as normotensive or prehypertensive as per the recommendation of the JNC-7 report. 1 Co-morbidities that were known to affect the test parameters were excluded from the study. Five millilitre of fasting venous blood was collected from all the subjects in bottles containing ethylenediaminetetraacetic acid. Whole blood was used to analyse reduced glutathione (GSH) and haemoglobin. Plasma was collected by centrifuging rest of the sample at 5000 g for 5 min at 41C and was used for the estimation of malondialdehyde (MDA) and glucose. Erythrocytes were washed with 0.9% saline and lysed with cold distilled water. Antioxidant enzymes were estimated using the lysate. Plasma glucose was estimated immediately and rest of the sample was stored at À701C for the estimation of MDA and protein carbonyl. MDA, protein carbonyl, reduced GSH, glutathione peroxidase and catalase were estimated using standard protocol. The results were expressed as mean7s.d. and were analysed using Student's unpaired t-test, Pearson's correlation test and regression analysis with adjustment for age and BMI.
The clinical characteristics of the subjects are shown in Table 1 . As shown in the table the study groups were well matched for age and BMI distribution with respect to their control groups. There was no significant difference in the levels of fasting blood glucose between the study groups. The levels of MDA, protein carbonyl, erythrocyte glutathione peroxidase activity were significantly increased and whole-blood reduced GSH and erythrocyte catalase activities were significantly reduced among the prehypertensive subjects when compared to controls. In PHT, GSH was significantly associated with MDA (r ¼ À0.436, P ¼ 0.014), catalase (r ¼ 0.517, P ¼ 0.003) and glutathione peroxidase (r ¼ À0.365, P ¼ 0.044). When Pearson's correlation analysis was performed, glutathione peroxidase correlated significantly with MDA (r ¼ 0.475, P ¼ 0.007) and catalase (r ¼ À0.457, P ¼ 0.010). Taken together, the results indicate the presence of oxidative stress in prehypertensives. MDA had significant positive correlation with both systolic BP (r ¼ 0.438, P ¼ 0.017) and diastolic BP (r ¼ 0.371, P ¼ 0.047) even after adjusting for the contribution of age and BMI.
In this study, for the first time, the presence of oxidative stress in prehypertensive subjects is reported. The latest JNC report on hypertension identifies PHT as one of the risk factors for developing hypertension. 1 Qureshi et al. 7 have reported association of PHT with high incidence of myocardial infarction and coronary heart disease. Although the exact mechanism involved in the development of cardiovascular complications in PHT is not well understood, oxidative stress may play a vital role in its pathogenesis. 5 Oxidative stress may contribute to the generation and maintenance of hypertension via the interaction with nitric oxide, the non-enzymatic generation of vasoconstrictive isoprostanes from arachidonic acid peroxidation and direct vasopressor action. 8 In the present study, we found an increase in the levels of oxidative stress markers like MDA and protein carbonyl. The increase in plasma MDA, an endproduct of polyunsaturated fatty acid peroxidation and protein carbonyl, a biomarker of protein oxidation in PHT patients, suggest that oxygen-free radicals may already have exerted their cytotoxic effects, and the extent of this injury is considerable enough to be reflected systemically in the early stage of the disease.
Among the elaborate antioxidant defence system of erythrocyte, reduced GSH, catalase and GSH peroxidase play important roles in neutralizing the deleterious effects of peroxides. 9 Thus, the decreased activity of catalase observed in prehypertensive patients can result in an increased accumulation of oxygen-free radicals. We also found that glutathione peroxidase activity was marginally elevated in the present study, and this elevation may be upregulated to combat the excess production of free radicals in prehypertensive subjects.
MDA was significantly associated with systolic and diastolic BP and reduced GSH correlated significantly with MDA, glutathione peroxide and catalase. We also found a considerable association of catalase with MDA and glutathione peroxide. These findings suggest a severe disturbance in the antioxidant defence mechanisms in PHT and, that may lead these subjects to a state of hypertension.
To conclude, our results suggest an imbalance in the oxidant/antioxidant ratio in prehypertensive subjects. This alteration in the antioxidant/oxidant system can possibly influence the progression of hypertension in man as has been shown in hypertensive rat.
Future epidemiological, genetic polymorphic studies to identify candidate antioxidant genes that are altered in the prehypertensive subjects are warranted. This will increase our understanding of the genetic modulation of antioxidant enzymes in these subjects and that will be useful for the development of molecular interventions in them. Experimental studies in animal models are also required to define whether dietary or supplemental antioxidants ameliorate these processes. It would also be worth to study and clarify the reported potential role of gender in generating oxidant/antioxidant imbalance in prehypertensive subjects. 
